Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH)

Typically moves ±8.12% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-13 ESTIMATED

Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH) has reported earnings 19 times since Aug 16, 2021. The stock moves an average of ±8.12% the day after reporting, closing higher 52.6% of the time. Its largest post-earnings gain was +15.9% (Aug 14, 2025) and its largest decline was -35.63% (Mar 31, 2025). The next earnings report is predicted for 2026-11-13 (estimated).

Earnings reactions

How RVPH moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±8.12%

Positive %

52.6%

Negative %

47.4%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 12, 2026	☽ POST	+0%	open_in_new
May 13, 2026	☽ POST	+0%	open_in_new
Mar 30, 2026	☀ PRE	-10.58%	open_in_new
Nov 13, 2025	☽ POST	-7.41%	open_in_new
Aug 14, 2025	☽ POST	+15.9%	open_in_new
May 15, 2025	☽ POST	+0.16%	open_in_new
Mar 31, 2025	☽ POST	-35.63%	open_in_new
Nov 14, 2024	☽ POST	-7.44%	open_in_new
Aug 14, 2024	☀ PRE	+3.17%	open_in_new
May 14, 2024	☀ PRE	+7.62%	open_in_new
Nov 14, 2023	☽ POST	-9.09%	open_in_new
Aug 14, 2023	☽ POST	+2.63%	open_in_new
May 15, 2023	☽ POST	-1.76%	open_in_new
Mar 30, 2023	☀ PRE	-7.42%	open_in_new
Nov 14, 2022	☽ POST	-19.8%	open_in_new
Aug 15, 2022	☽ POST	-7.43%	open_in_new
May 16, 2022	☽ POST	+12.25%	open_in_new
Mar 15, 2022	☽ POST	+0.57%	open_in_new
Aug 16, 2021	☀ PRE	+5.51%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.12%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13G/A

description SCHEDULE 13G

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260813	open_in_new SEC.gov
10-Q	20260812	open_in_new SEC.gov
8-K	20260812	open_in_new SEC.gov
SCHEDULE 13G/A	20260803	open_in_new SEC.gov
SCHEDULE 13G/A	20260731	open_in_new SEC.gov
25-NSE	20260710	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G	20260514	open_in_new SEC.gov
10-Q	20260513	open_in_new SEC.gov
8-K	20260513	open_in_new SEC.gov

Frequently asked about RVPH earnings

When does Reviva Pharmaceuticals Holdings, Inc. Common Stock report earnings next? expand_more

Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does RVPH stock move after earnings? expand_more

Over 19 reports, RVPH has moved an average of ±8.12% the session after earnings, closing higher 52.6% of the time.

What was RVPH's biggest post-earnings move? expand_more

RVPH's largest post-earnings gain on record was +15.9% on Aug 14, 2025, and its largest decline was -35.63% on Mar 31, 2025.

Where can I find Reviva Pharmaceuticals Holdings, Inc. Common Stock's SEC filings? expand_more

All of Reviva Pharmaceuticals Holdings, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.